XML 22 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities:    
Net income (loss) $ 33,820us-gaap_NetIncomeLoss $ (46,201)us-gaap_NetIncomeLoss
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Non-cash royalty revenue related to sale of future royalties (3,962)nktr_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties (5,773)nktr_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
Non-cash interest expense on liability related to sale of future royalties 5,050nktr_NonCashInterestExpenseRelatedToSaleOfRoyalties 5,387nktr_NonCashInterestExpenseRelatedToSaleOfRoyalties
Stock-based compensation 5,177us-gaap_AllocatedShareBasedCompensationExpense 4,361us-gaap_AllocatedShareBasedCompensationExpense
Depreciation and amortization 2,973us-gaap_DepreciationAndAmortization 3,264us-gaap_DepreciationAndAmortization
Other non-cash transactions (938)us-gaap_OtherNoncashIncomeExpense 777us-gaap_OtherNoncashIncomeExpense
Changes in operating assets and liabilities:    
Accounts receivable, net 722us-gaap_IncreaseDecreaseInAccountsReceivable 374us-gaap_IncreaseDecreaseInAccountsReceivable
Inventory 441us-gaap_IncreaseDecreaseInInventories 580us-gaap_IncreaseDecreaseInInventories
Other assets 2,809us-gaap_IncreaseDecreaseInOtherOperatingAssets (718)us-gaap_IncreaseDecreaseInOtherOperatingAssets
Accounts payable 2,241us-gaap_IncreaseDecreaseInAccountsPayable (6,126)us-gaap_IncreaseDecreaseInAccountsPayable
Accrued compensation 3,607us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities (4,827)us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities
Accrued expenses 1,811us-gaap_IncreaseDecreaseInAccruedLiabilities 693us-gaap_IncreaseDecreaseInAccruedLiabilities
Accrued clinical trial expenses 1,039nktr_IncreaseDecreaseInAccruedClinicalTrialExpenses (3,179)nktr_IncreaseDecreaseInAccruedClinicalTrialExpenses
Interest payable (3,750)us-gaap_IncreaseDecreaseInInterestPayableNet (3,750)us-gaap_IncreaseDecreaseInInterestPayableNet
Deferred revenue 1,993us-gaap_IncreaseDecreaseInDeferredRevenue (5,957)us-gaap_IncreaseDecreaseInDeferredRevenue
Other liabilities 10,279us-gaap_IncreaseDecreaseInOtherOperatingLiabilities (1,195)us-gaap_IncreaseDecreaseInOtherOperatingLiabilities
Net cash provided by (used in) operating activities 63,312us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (62,290)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Maturities of investments 73,434us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities 56,972us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
Purchases of investments (24,432)us-gaap_PaymentsToAcquireAvailableForSaleSecurities (110,661)us-gaap_PaymentsToAcquireAvailableForSaleSecurities
Sale of investments 5,215us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities  
Purchases of property, plant and equipment (1,059)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (4,524)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Net cash provided by (used in) investing activities 53,158us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (58,213)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Payment of capital lease obligations (1,098)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (825)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Repayment of proceeds from sale of future royalties   (7,000)nktr_RepaymentOfAndProceedsFromSaleOfFutureRoyaltiesNetOfTransactionCosts
Issuance of common stock, net of issuance costs   116,619nktr_ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
Proceeds from shares issued under equity compensation plans 1,685us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans 5,074us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
Net cash provided by financing activities 587us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 113,868us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Effect of exchange rates on cash and cash equivalents 30us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 11us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net increase (decrease) in cash and cash equivalents 117,087us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (6,624)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of period 12,365us-gaap_CashAndCashEquivalentsAtCarryingValue 39,067us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of period 129,452us-gaap_CashAndCashEquivalentsAtCarryingValue 32,443us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 7,855us-gaap_InterestPaid $ 7,961us-gaap_InterestPaid